The US Bankruptcy Court granted an order for the extension of the exclusivity periods for MabVax Therapeutics Holdings, Inc. on November 6, 2019. As per the order, the debtor’s exclusivity period to file its plan and to solicit votes on its plan, have been extended by 120 days i.e. up to March 17, 2020 and May 18, 2020, respectively.